Variant report

Variant	nsv916268
Chromosome Location	chr2:50783130-50807050
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr2:50783410..50785282-chr2:50787313..50790296,2	K562	blood:
2	chr2:50783410..50785282-chr2:50787313..50790296,2	K562	blood:
3	chr2:50799576..50800227-chr5:50253074..50253737,2	MCF-7	breast:

Extended variants
information (count: 753 )
Associated
traits (count: 104 )

Variant overlapped rSNPs/rCNVs (count:753 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs376131203	chr2:50783183-50783184	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs369672474	chr2:50783199-50783200	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs563028584	chr2:50783209-50783210	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs61134387	chr2:50783229-50783230	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs78244342	chr2:50783233-50783234	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs566568360	chr2:50783253-50783254	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs78723515	chr2:50783321-50783322	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs533837496	chr2:50783363-50783364	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs549021309	chr2:50783423-50783424	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs544618002	chr2:50783431-50783432	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs567296541	chr2:50783446-50783447	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs529394095	chr2:50783528-50783529	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs373467652	chr2:50783555-50783556	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs117064285	chr2:50783573-50783574	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs558387581	chr2:50783643-50783644	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs199504883	chr2:50783658-50783659	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs200020022	chr2:50783673-50783674	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs182942703	chr2:50783729-50783730	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs547158271	chr2:50783736-50783737	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs577858137	chr2:50783756-50783757	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs538830848	chr2:50783771-50783772	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs553646357	chr2:50783776-50783777	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs140218166	chr2:50783777-50783778	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs77675260	chr2:50783778-50783779	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs188849568	chr2:50783816-50783817	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs192449453	chr2:50783826-50783827	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs544195055	chr2:50783872-50783873	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs77832473	chr2:50783904-50783905	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs62142293	chr2:50783942-50783943	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs551965082	chr2:50783983-50783984	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs560452531	chr2:50784035-50784036	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs527864783	chr2:50784054-50784055	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs150310413	chr2:50784062-50784063	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs554752451	chr2:50784066-50784067	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs552105249	chr2:50784078-50784079	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs529515087	chr2:50784090-50784091	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs537888430	chr2:50784133-50784134	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs549465344	chr2:50784138-50784139	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs138038689	chr2:50784171-50784172	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs538525779	chr2:50784177-50784178	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs572016357	chr2:50784188-50784189	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs373899402	chr2:50784215-50784216	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs571939318	chr2:50784225-50784226	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs367755613	chr2:50784226-50784227	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs13393910	chr2:50784245-50784246	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs555485532	chr2:50784250-50784251	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs569219506	chr2:50784282-50784283	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs573749129	chr2:50784316-50784317	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs76935614	chr2:50784324-50784325	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs183844330	chr2:50784331-50784332	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:104)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17387387	CNVD
Neuroblastoma	17533364	CNVD
Neuroblastoma	18923191	CNVD
Endometrial cancer	22040021	CNVD
Adrenal tumor	17535989	CNVD
Breast cancer	21264507	CNVD
Basal cell lymphoma	17053054	CNVD
Medulloblastoma	17522785	CNVD
Cancer	23418310	CNVD
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
lymphocytic leukemia	21291569	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	20505157	CNVD
Autism	17483303	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Medulloblastoma	20607354	CNVD
Leukemia	18628472	CNVD
Autism	22495311	CNVD
Autism	18522746	CNVD
Breast cancer	21785460	CNVD
Lung cancer	18438408	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21508638	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
Colorectal cancer	16272173	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Williams Syndrome	20824207	CNVD
Breast cancer	16272173	CNVD
Lung cancer	17297452	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Ovarian cancer	21720365	CNVD
abnormal development	18461090	CNVD
Breast cancer	21364760	CNVD
Schizophrenia	20433910	CNVD
Autism	21701786	CNVD
Attention deficit hyperactivity disorder	21324949	CNVD
Austim spectrum disorder	21302340	CNVD
Schizophrenia	20587603	CNVD
Schizophrenia	20553308	CNVD
Autism	22241247	CNVD
Myelofibrosis	22110671	CNVD
Lung adenocarcinoma	17086460	CNVD
Retinoblastoma	22278416	CNVD
Cancer	21183584	CNVD
Breast cancer	16397240	CNVD
Acute lymphoblastic leukemia	18768390	CNVD
Mental retardation	19521722	CNVD
Schizophrenia	18990708	CNVD
Schizophrenia	18940311	CNVD
Schizophrenia	19348701	CNVD
Schizophrenia	18945720	CNVD
Schizophrenia	19571808	CNVD
Prostate cancer	16573809	CNVD
Neuroticism	17667963	CNVD
Schizophrenia	19443537	CNVD
Schizophrenia	19546859	CNVD
Autism	17322880	CNVD
Lung cancer	17086460	CNVD
Chronic lymphocytic leukemia	17053054	CNVD
Hereditary non-polyposis colorectal cancer	19566914	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Basal cell lymphoma	21115979	CNVD
Cognitive impairment	21505072	CNVD
Psychiatric disorder	19734545	CNVD
Autism	20844286	CNVD
Schizophrenia	20838587	CNVD
Schizophrenia	20718829	CNVD
Autism	19218893	CNVD
Autism	22209245	CNVD
Neuropsychiatric disorder	21827697	CNVD
Schizophrenia	22118685	CNVD
Autism	20663923	CNVD
Schizophrenia	21285140	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21990379	CNVD
Schizophrenia	22885689	CNVD
Autism	20964600	CNVD
Schizophrenia	19521646	CNVD
Attention deficit hyperactivity disorder	22214315	CNVD
Chronic motor tic disorder	22214315	CNVD
Schizophrenia	22214315	CNVD
Mental retardation	19896112	CNVD
Acute myeloid leukemia	20729466	CNVD

Chromatin state (count:31 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:50766200-50791800	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
2	chr2:50780000-50791400	Weak transcription	Brain Germinal Matrix	brain
3	chr2:50780200-50784000	Weak transcription	Fetal Heart	heart
4	chr2:50783200-50785800	Enhancers	Hela-S3	cervix
5	chr2:50783800-50785000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
6	chr2:50784000-50785200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
7	chr2:50784000-50785200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
8	chr2:50784000-50785200	Enhancers	NH-A	brain
9	chr2:50784000-50785600	Enhancers	Fetal Heart	heart
10	chr2:50784200-50784400	Enhancers	HMEC	breast
11	chr2:50784200-50784600	Enhancers	Stomach Mucosa	stomach
12	chr2:50784200-50785000	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
13	chr2:50784200-50785400	Enhancers	NHEK	skin
14	chr2:50784400-50785200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
15	chr2:50784600-50785200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
16	chr2:50784600-50785400	Enhancers	HUES64 Cell Line	embryonic stem cell
17	chr2:50785000-50785200	Enhancers	HMEC	breast
18	chr2:50785000-50785400	Enhancers	iPS-15b Cell Line	embryonic stem cell
19	chr2:50785000-50785800	Enhancers	iPS-18 Cell Line	embryonic stem cell
20	chr2:50790400-50791200	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
21	chr2:50790400-50791200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
22	chr2:50790600-50791200	Enhancers	Colon Smooth Muscle	Colon
23	chr2:50790800-50791000	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
24	chr2:50791000-50795600	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
25	chr2:50791600-50793000	Enhancers	Cortex derived primary cultured neurospheres	brain
26	chr2:50791800-50793000	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
27	chr2:50792000-50793200	Enhancers	Fetal Brain Male	brain
28	chr2:50792200-50793000	Enhancers	Fetal Brain Female	brain
29	chr2:50802000-50802400	Enhancers	Fetal Heart	heart
30	chr2:50802200-50802400	Enhancers	Fetal Brain Female	brain
31	chr2:50802600-50832400	Weak transcription	Fetal Brain Female	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links